Evidence map›Paper›PMID 33564767›Full record

ArticlebioRxiv : the preprint server for biology2021

Variation in predicted COVID-19 risk among lemurs and lorises.

Amanda D Melin, Joseph D Orkin, Mareike C Janiak, Alejandro Valenzuela, Lukas Kuderna, Frank Marrone, Hasinala Ramangason, Julie E Horvath, Christian Roos, Andrew C Kitchener and 24 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Amanda D MelinDepartment of Anthropology and Archaeology, University of Calgary, Canada.
Joseph D OrkinExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
Mareike C JaniakSchool of Science, Engineering & Environment, University of Salford, United Kingdom.
Alejandro ValenzuelaExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
Lukas KudernaExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
Frank MarroneDepartment of Chemistry, New York University, United States.
Hasinala RamangasonDepartment of Anthropology and Archaeology, University of Calgary, Canada.
Julie E HorvathGenomics & Microbiology Research Laboratory, North Carolina Museum of Natural Sciences, Raleigh, NC, USA.
Christian RoosGene Bank of Primates and Primate Genetics Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göettingen, Germany.
Andrew C KitchenerDepartment of Natural Sciences, National Museums Scotland and School of Geosciences, University of Edinburgh, Edinburgh, United Kingdom.
Chiea Chuen KhorGenome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
Weng Khong LimSingHealth Duke-NUS Institute of Precision Medicine, Singapore Health Services, Singapore.
Jessica G H LeeDepartment of Conservation, Research and Veterinary Services, Wildlife Reserves Singapore, Singapore.
Patrick TanGenome Institute of Singapore, Agency for Science, Technology and Research, Singapore.
Govindhaswamy UmapathyCSIR-Laboratory for the Conservation of Endangered Species, Centre for Cellular and Molecular Biology, Hyderabad, India.
Muthuswamy RaveendranHuman Genome Sequencing Center and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
R Alan HarrisHuman Genome Sequencing Center and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Ivo GutUniversitat Pompeu Fabra (UPF), Barcelona, Spain.
Marta GutUniversitat Pompeu Fabra (UPF), Barcelona, Spain.
Esther LizanoExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
Tilo NadlerCuc Phuong Commune, Nho Quan District, Ninh Binh Province, Vietnam.
Dietmar ZinnerCognitive Ethology Laboratory, German Primate Center, Leibniz Institute for Primate Research, Goettingen, Germany.
Steig E JohnsonDepartment of Anthropology and Archaeology, University of Calgary, Canada.
Erich D JarvisThe Vertebrate Genomes Lab, The Rockefeller University, New York, United States.
Olivier FedrigoThe Vertebrate Genomes Lab, The Rockefeller University, New York, United States.
Dongdong WuState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
Guojie ZhangVillum Center for Biodiversity Genomics, Section for Ecology and Evolution, Department of Biology, University of Copenhagen, Denmark.
Kyle Kai-How FarhArtificial Intelligence Lab, Illumina Inc, San Diego, CA, USA.
Jeffrey RogersHuman Genome Sequencing Center and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Tomas Marques-BonetExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
Arcadi NavarroExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
David JuanExperimental and Health Sciences Department (DCEXS), Institut de Biologia Evolutiva, Universitat Pompeu Fabra-CSIC, Barcelona, Spain.
Paramjit S AroraDepartment of Chemistry, New York University, United States.
James P HighamDepartment of Anthropology, New York University, United States.

Funding

Protein Domain Mimics as Modulators of Biomolecular InteractionsR35GM130333 · NIGMS · NEW YORK UNIVERSITY · PI Paramjit S Arora · 2019 to 2026
$6.0M
NIGMS NIH HHS R35 GM130333
6 · The paper itself

Abstract

The novel coronavirus SARS-CoV-2, which in humans leads to the disease COVID-19, has caused global disruption and more than 1.5 million fatalities since it first emerged in late 2019. As we write, infection rates are currently at their highest point globally and are rising extremely rapidly in some areas due to more infectious variants. The primary viral target is the cellular receptor angiotensin-converting enzyme-2 (ACE2). Recent sequence analyses of the

Identifiers

PMID33564767
PMCPMC7872355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.